287 related articles for article (PubMed ID: 31638221)
1. Upregulation of miR‑132‑3p in cholangiocarcinoma tissues: A study based on RT‑qPCR, The Cancer Genome Atlas miRNA sequencing, Gene Expression Omnibus microarray data and bioinformatics analyses.
Wu HY; Xia S; Liu AG; Wei MD; Chen ZB; Li YX; He Y; Liao MJ; Hu QP; Pan SL
Mol Med Rep; 2019 Dec; 20(6):5002-5020. PubMed ID: 31638221
[TBL] [Abstract][Full Text] [Related]
2. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
4. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma.
Song W; Miao DL; Chen L
Biochem Biophys Res Commun; 2018 Dec; 506(4):1004-1012. PubMed ID: 30404735
[TBL] [Abstract][Full Text] [Related]
6. Cholangiocarcinoma‑associated genes identified by integrative analysis of gene expression data.
Zhong W; Dai L; Liu J; Zhou S
Mol Med Rep; 2018 Apr; 17(4):5744-5753. PubMed ID: 29436659
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis of genome-wide profiles coupled with Connectivity Map database mining to identify potential therapeutic targets for cholangiocarcinoma.
Lin P; Zhong XZ; Wang XD; Li JJ; Zhao RQ; He Y; Jiang YQ; Huang XW; Chen G; He Y; Yang H
Oncol Rep; 2018 Dec; 40(6):3189-3198. PubMed ID: 30272356
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma.
Li H; Long J; Xie F; Kang K; Shi Y; Xu W; Wu X; Lin J; Xu H; Du S; Xu Y; Zhao H; Zheng Y; Gu J
Oncol Rep; 2019 Nov; 42(5):1833-1842. PubMed ID: 31545466
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
Likhitrattanapisal S; Tipanee J; Janvilisri T
Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of microRNA in cholangiocarcinoma identified through a meta-analysis of microRNA profiling.
Likhitrattanapisal S; Kumkate S; Ajawatanawong P; Wongprasert K; Tohtong R; Janvilisri T
World J Gastroenterol; 2020 Aug; 26(29):4356-4371. PubMed ID: 32848339
[TBL] [Abstract][Full Text] [Related]
12. Identification of biomarkers of intrahepatic cholangiocarcinoma via integrated analysis of mRNA and miRNA microarray data.
Chen Y; Liu D; Liu P; Chen Y; Yu H; Zhang Q
Mol Med Rep; 2017 Mar; 15(3):1051-1056. PubMed ID: 28098904
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes.
Kitdumrongthum S; Metheetrairut C; Charoensawan V; Ounjai P; Janpipatkul K; Panvongsa W; Weerachayaphorn J; Piyachaturawat P; Chairoungdua A
Life Sci; 2018 Oct; 210():65-75. PubMed ID: 30165035
[TBL] [Abstract][Full Text] [Related]
14. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
Qiu G; Ma D; Li F; Sun D; Zeng Z
Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma.
Wang X; Hu KB; Zhang YQ; Yang CJ; Yao HH
Cancer Biomark; 2018; 23(4):549-559. PubMed ID: 30452401
[TBL] [Abstract][Full Text] [Related]
16. Novel miRNA Predicts Survival and Prognosis of Cholangiocarcinoma Based on RNA-seq Data and
Yao Y; Jiao D; Liu Z; Chen J; Zhou X; Li Z; Li J; Han X
Biomed Res Int; 2020; 2020():5976127. PubMed ID: 33490245
[TBL] [Abstract][Full Text] [Related]
17. Expressional and prognostic value of HPCAL1 in cholangiocarcinoma via integrated bioinformatics analyses and experiments.
Ma M; Zeng G; Li J; Liang J; Huang L; Chen J; Lai J
Cancer Med; 2023 Jan; 12(1):824-836. PubMed ID: 35645147
[TBL] [Abstract][Full Text] [Related]
18. The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells.
Utaijaratrasmi P; Vaeteewoottacharn K; Tsunematsu T; Jamjantra P; Wongkham S; Pairojkul C; Khuntikeo N; Ishimaru N; Sirivatanauksorn Y; Pongpaibul A; Thuwajit P; Thuwajit C; Kudo Y
Mol Cancer; 2018 Jan; 17(1):10. PubMed ID: 29347950
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma.
Lin KY; Ye H; Han BW; Wang WT; Wei PP; He B; Li XJ; Chen YQ
Oncogene; 2016 Jun; 35(26):3376-86. PubMed ID: 26455324
[TBL] [Abstract][Full Text] [Related]
20. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.
Zhang R; Zhang LJ; Yang ML; Huang LS; Chen G; Feng ZB
Mol Med Rep; 2018 Feb; 17(2):2211-2228. PubMed ID: 29207133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
